Natalizumab Discontinuation in Pregnancy: Evaluating Relapse Risk in MS Patients After the Second Trimester (P10-1.010)

To evaluate the impact of continuing Natalizumab during pregnancy on relapse risk and maternal-fetal outcomes in MS patients and determine the optimal duration of therapy, considering the relative immune protection in the third trimester.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000210713
Primary Topic
Pregnancy and Medication Impact
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Natalizumab Discontinuation in Pregnancy: Evaluating Relapse Risk in MS Patients After the Second Trimester (P10-1.010)

Saud Sadiq, Mahsa Mohajery, Shannon Brewi
Neurology
Pregnancy and Medication Impact
article

Natalizumab Discontinuation in Pregnancy: Evaluating Relapse Risk in MS Patients After the Second Trimester (P10-1.010)

Saud Sadiq, Mahsa Mohajery, Shannon Brewi
article en

Abstract

To evaluate the impact of continuing Natalizumab during pregnancy on relapse risk and maternal-fetal outcomes in MS patients and determine the optimal duration of therapy, considering the relative immune protection in the third trimester.

NeurologyVol. 104(7_Supplement_1)
Tisch Hospital (US)
Openalex Percentile: Top 90%
Pregnancy and Medication Impact
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Natalizumab Discontinuation in Pregnancy: Evaluating Relapse Risk in MS Patients After the Second Trimester (P10-1.010) — Saud Sadiq, Mahsa Mohajery, et al. · Neurology (2025) | TGRS Research Map | TGRS